As of Aug 17
| +0.11 / +4.14%|
The 2 analysts offering 12-month price forecasts for Evogene Ltd have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +188.81% increase from the last price of 2.77.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.